Baidu
map

Clin Exp Optom:圆锥角膜后房型有晶状体人工晶状体植入术的长期结果

2018-03-26 cuiguizhong MedSci原创

伊朗伊朗医科大学Rassoul Akram医院眼科研究中心的Hashemian SJ近日在Clin Exp Optom发表了一项重要工作,对后房人工晶状体(pIOL)植入的长期安全性、有效性、稳定性和可预测性等进行了研究,来校正与圆锥角膜相关的近视和近视散光。

伊朗伊朗医科大学Rassoul Akram医院眼科研究中心的Hashemian SJ近日在Clin Exp Optom发表了一项重要工作,对后房人工晶状体(pIOL)植入的长期安全性、有效性、稳定性和可预测性等进行了研究,来校正与圆锥角膜相关的近视和近视散光。

他们对移植Visian ICMV4 pIOL(STAAR Surgical)长达5年的13名患者的23只角膜眼进行了未矫正远视力(UDVA)、最佳矫正视力矫正远视力(BSCDVA)、屈光度和不良反应的评估。

分析结果,发现手术后五年,平均等效球镜和圆柱分别从手术前的-5.35±2.82D和-3.14±1.58D变为-0.78±1.31D和-1.56±1.53D。术前平均斯内伦小数BSCDVA为0.60±0.20。术后平均UDVA和BSCDVA分别变为0.74±0.22和0.88±0.16。总共82.5%的眼睛术后达到6/12或更好的UDVA。平均安全性和有效性指数分别为1.47±0.32和1.24±0.34。没有眼睛失去一条视力线,19只眼睛获得了一条或多条线视力。内皮细胞损失约为7.88%。眼压、陡峭、平坦和平均角膜曲率没有显着变化,晶状体也呈现透明状态。

因此,他们认为目前研究的临床结果证实,植入式胶原镜片(复曲面和非复曲面)对于校正与圆锥角膜相关的近视和近视散光具有良好的安全性、有效性和可预测性。

原文出处:

Hashemian, S.J., et al., Long-term outcomes of posterior chamber phakic intraocular lens implantation in keratoconus. Clin Exp Optom, 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1946324, encodeId=71eb194632473, content=<a href='/topic/show?id=6aad2480499' target=_blank style='color:#2F92EE;'>#人工晶状体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24804, encryptionId=6aad2480499, topicName=人工晶状体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Sep 17 17:17:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723757, encodeId=4a2a1e2375742, content=<a href='/topic/show?id=ac899e0343c' target=_blank style='color:#2F92EE;'>#长期结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97034, encryptionId=ac899e0343c, topicName=长期结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6a33536665, createdName=zhucaizhong7777, createdTime=Wed Dec 12 12:17:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736125, encodeId=4dbc1e361255d, content=<a href='/topic/show?id=05564121e2a' target=_blank style='color:#2F92EE;'>#圆锥角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41217, encryptionId=05564121e2a, topicName=圆锥角膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2aeb34082524, createdName=lilili1115, createdTime=Thu Nov 01 01:17:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301404, encodeId=41c3301404b9, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sat Mar 31 07:22:58 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349130, encodeId=07af134913055, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520464, encodeId=fa7715204647b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1946324, encodeId=71eb194632473, content=<a href='/topic/show?id=6aad2480499' target=_blank style='color:#2F92EE;'>#人工晶状体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24804, encryptionId=6aad2480499, topicName=人工晶状体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Sep 17 17:17:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723757, encodeId=4a2a1e2375742, content=<a href='/topic/show?id=ac899e0343c' target=_blank style='color:#2F92EE;'>#长期结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97034, encryptionId=ac899e0343c, topicName=长期结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6a33536665, createdName=zhucaizhong7777, createdTime=Wed Dec 12 12:17:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736125, encodeId=4dbc1e361255d, content=<a href='/topic/show?id=05564121e2a' target=_blank style='color:#2F92EE;'>#圆锥角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41217, encryptionId=05564121e2a, topicName=圆锥角膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2aeb34082524, createdName=lilili1115, createdTime=Thu Nov 01 01:17:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301404, encodeId=41c3301404b9, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sat Mar 31 07:22:58 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349130, encodeId=07af134913055, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520464, encodeId=fa7715204647b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1946324, encodeId=71eb194632473, content=<a href='/topic/show?id=6aad2480499' target=_blank style='color:#2F92EE;'>#人工晶状体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24804, encryptionId=6aad2480499, topicName=人工晶状体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Sep 17 17:17:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723757, encodeId=4a2a1e2375742, content=<a href='/topic/show?id=ac899e0343c' target=_blank style='color:#2F92EE;'>#长期结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97034, encryptionId=ac899e0343c, topicName=长期结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6a33536665, createdName=zhucaizhong7777, createdTime=Wed Dec 12 12:17:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736125, encodeId=4dbc1e361255d, content=<a href='/topic/show?id=05564121e2a' target=_blank style='color:#2F92EE;'>#圆锥角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41217, encryptionId=05564121e2a, topicName=圆锥角膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2aeb34082524, createdName=lilili1115, createdTime=Thu Nov 01 01:17:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301404, encodeId=41c3301404b9, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sat Mar 31 07:22:58 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349130, encodeId=07af134913055, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520464, encodeId=fa7715204647b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1946324, encodeId=71eb194632473, content=<a href='/topic/show?id=6aad2480499' target=_blank style='color:#2F92EE;'>#人工晶状体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24804, encryptionId=6aad2480499, topicName=人工晶状体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Sep 17 17:17:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723757, encodeId=4a2a1e2375742, content=<a href='/topic/show?id=ac899e0343c' target=_blank style='color:#2F92EE;'>#长期结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97034, encryptionId=ac899e0343c, topicName=长期结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6a33536665, createdName=zhucaizhong7777, createdTime=Wed Dec 12 12:17:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736125, encodeId=4dbc1e361255d, content=<a href='/topic/show?id=05564121e2a' target=_blank style='color:#2F92EE;'>#圆锥角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41217, encryptionId=05564121e2a, topicName=圆锥角膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2aeb34082524, createdName=lilili1115, createdTime=Thu Nov 01 01:17:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301404, encodeId=41c3301404b9, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sat Mar 31 07:22:58 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349130, encodeId=07af134913055, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520464, encodeId=fa7715204647b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2018-03-31 紫迎馨

    关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1946324, encodeId=71eb194632473, content=<a href='/topic/show?id=6aad2480499' target=_blank style='color:#2F92EE;'>#人工晶状体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24804, encryptionId=6aad2480499, topicName=人工晶状体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Sep 17 17:17:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723757, encodeId=4a2a1e2375742, content=<a href='/topic/show?id=ac899e0343c' target=_blank style='color:#2F92EE;'>#长期结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97034, encryptionId=ac899e0343c, topicName=长期结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6a33536665, createdName=zhucaizhong7777, createdTime=Wed Dec 12 12:17:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736125, encodeId=4dbc1e361255d, content=<a href='/topic/show?id=05564121e2a' target=_blank style='color:#2F92EE;'>#圆锥角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41217, encryptionId=05564121e2a, topicName=圆锥角膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2aeb34082524, createdName=lilili1115, createdTime=Thu Nov 01 01:17:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301404, encodeId=41c3301404b9, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sat Mar 31 07:22:58 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349130, encodeId=07af134913055, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520464, encodeId=fa7715204647b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2018-03-28 snowpeakxu
  6. [GetPortalCommentsPageByObjectIdResponse(id=1946324, encodeId=71eb194632473, content=<a href='/topic/show?id=6aad2480499' target=_blank style='color:#2F92EE;'>#人工晶状体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24804, encryptionId=6aad2480499, topicName=人工晶状体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Sep 17 17:17:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723757, encodeId=4a2a1e2375742, content=<a href='/topic/show?id=ac899e0343c' target=_blank style='color:#2F92EE;'>#长期结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97034, encryptionId=ac899e0343c, topicName=长期结果)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6a33536665, createdName=zhucaizhong7777, createdTime=Wed Dec 12 12:17:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736125, encodeId=4dbc1e361255d, content=<a href='/topic/show?id=05564121e2a' target=_blank style='color:#2F92EE;'>#圆锥角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41217, encryptionId=05564121e2a, topicName=圆锥角膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2aeb34082524, createdName=lilili1115, createdTime=Thu Nov 01 01:17:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301404, encodeId=41c3301404b9, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sat Mar 31 07:22:58 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349130, encodeId=07af134913055, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520464, encodeId=fa7715204647b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Mar 28 13:17:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2018-03-28 jiyangfei

相关资讯

Cornea.:不同照射强度和照射时间对加速角膜胶原交联治疗的角膜密度变化:1年随访研究!

土耳其马尔马拉大学医学院眼科系的Akkaya Turhan S近日在Cornea.发表了他们团队近期的一项工作,他们在圆锥角膜病人中,比较两种不同方案加速角膜胶原交联(A-CXL)对角膜密度的变化。

Ophthalmol Ther: 圆锥角膜治疗规范

希腊Gennimatas医院第一眼科和卡波第斯特大学的Andreanos KD教授近日在Ophthalmol Ther发表了一篇综述,系统的总结了目前对于圆锥角膜的治疗措施,并对它们的作用进行了论述。

Eye Contact Lens:刚性透气性隐形眼镜对圆锥角膜患者内皮细胞的影响!

土耳其伊斯坦布尔大学Cerrahpasa医学院眼科的Dogan C近日在Eye Contact Lens发表了一项重要的工作,他们在使用坚硬的透气性(RGP)隐形眼镜的患者和不使用隐形眼镜的健康人之间,比较了患圆锥角膜患者的角膜内皮细胞之间的不同。

Baidu
map
Baidu
map
Baidu
map